A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Institute of Hematology & Blood Diseases Hospital, China
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
St. Jude Children's Research Hospital
Dana-Farber Cancer Institute
Center for International Blood and Marrow Transplant Research
Masonic Cancer Center, University of Minnesota
St. Petersburg State Pavlov Medical University
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
University of Pennsylvania
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
Janssen Research & Development, LLC
Beijing Boren Hospital
Beijing Boren Hospital
Thomas Jefferson University
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
City of Hope Medical Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Gruppo Italiano Malattie EMatologiche dell'Adulto
H. Lee Moffitt Cancer Center and Research Institute
Sellas Life Sciences Group
Astellas Pharma Inc
Stanford University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Amgen
St. Petersburg State Pavlov Medical University
University College, London
The First Affiliated Hospital of Soochow University
Seattle Children's Hospital
Institute of Hematology and Blood Transfusion, Czech Republic
Aarhus University Hospital
Fred Hutchinson Cancer Center
Novartis
University of Alabama at Birmingham
Ain Shams University
Servier
University of Nebraska
Washington University School of Medicine
University of Nebraska
University of Nebraska
M.D. Anderson Cancer Center
University of Nebraska
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota